在接受VTE治疗的儿童中,复发性血栓和严重出血
Stephanie F Lenahan1, Anne Blackmore1, Matthew Fenchel2
1Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States.
Blood advances
|April 16, 2025
概括
儿科静脉血栓塞栓症 (VTE) 的复发率很高,中央静脉导管,炎症性肠病和静脉异常是关键风险因素. 在患有VTE的儿童中,抗凝固药通常是安全的,具有较低的重大出血风险.
科学领域:
- 儿科血液学 儿科血液学
- 血管医学 血管医学
- 临床血栓形成 临床血栓形成
背景情况:
- 儿童复发性静脉血栓塞栓症 (VTE) 的危险因素尚未得到充分定义.
- 对于儿科患者抗凝剂治疗的安全性仍然存在担忧.
- 了解这些因素对于有效治疗儿童的VTE至关重要.
研究的目的:
- 为了确定儿童复发性VTE的发病率.
- 确定与儿科患者静脉瘤复发相关的危险因素.
- 评估在接受抗凝药的VTE儿童中大出血的发生率.
主要方法:
- 一个单中心的队列研究,嵌套病例控制设计.
- 包括在2015年至2022年期间被诊断患有VTE的632名儿科患者.
- 统计分析包括单变量和多变量逻辑回归来确定风险因素和出血率.
主要成果:
- 静脉瘤复发率为每100人/年13.7人.
- 复发的重大风险因素包括中央静脉导管,炎症性肠病,肠道衰竭和解剖静脉异常.
- 严重出血发生的低率为每100人年2.2人.
结论:
- 患有VTE的儿科患者具有复发的高风险.
- 在患有VTE的儿童中,治疗性抗凝血与较低的重大出血风险有关.
- 出血的风险不应该阻止抗凝治疗,对于高风险儿童,可以考虑延长治疗.
相关概念视频
Disorders of Hemostasis
651
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
651
Esophageal Varices-II: Clinical Features and Management
27
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
27
Anticoagulant Drugs: Low-Molecular-Weight Heparins
548
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
548
Esophageal Varices-I: Introduction
51
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
51
Extrinsic and Intrinsic Pathways of Hemostasis
4.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.2K
Introduction to Hemostasis
4.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.5K


